Answers are grounded in this paper and cite their sources.
Unlike the other hemoglobinopathies, few researches have been published concerning α -thalassemia in Morocco. The epidemiological features and the mutation spectrum of this disease are still unknown. This regional newborn screening is the first to study α -thalassemia in the north of Morocco. During the period from January 2015 to December 2016, 1658 newborns umbilical blood samples were investigated. Suspected newborns were screened for α -globin defects using Gap-PCR and Multiplex Ligation-dependent Probe Amplification technique. The prevalence of α -thalassemia, its mutation spectrum, and its allelic frequencies were described for the first time in Morocco. Six different α -globin genetic disorders were detected in 16 neonates. This screening valued the prevalence of α -thalassemia in the studied population at 0.96% and showed the wide mutation spectrum and the heterogeneous geographical distribution of the disease. A high rate of carriers was observed in Laouamra, a rural commune in Larache province. Heterogeneity of α -globin alleles in Morocco explains the high variability of α -thalassemia severity. This diversity reflects the anthropological history of the country. These results would contribute to the prevention of thalassemia in Morocco directing the design of a nationwide screening strategy and awareness campaign.
No takes yet. Share an insight, caveat, or question.
Laghmich et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: